Please use this identifier to cite or link to this item:
Title: The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer's Dementia
Author: Folch, Jaume
Olloquequi González, Jordi
Ettcheto Arriola, Miren
Busquets Figueras, Oriol
Sánchez-López, E. (Elena)
Cano Fernández, Amanda
Espinosa Jiménez, Triana
García López, María Luisa
Beas Zárate, Carlos
Casadesús, Gemma
Bulló, Mònica
Auladell i Costa, M. Carme
Camins Espuny, Antoni
Keywords: Malaltia d'Alzheimer
Receptors d'insulina
Alzheimer's disease
Insulin receptors
Issue Date: Sep-2019
Publisher: Frontiers Media
Abstract: Nowadays, Alzheimer's disease (AD) is a severe sociological and clinical problem. Since it was first described, there has been a constant increase in its incidence and, for now, there are no effective treatments since current approved medications have only shown short-term symptomatic benefits. Therefore, it is imperative to increase efforts in the search for molecules and non-pharmacological strategies that are capable of slowing or stopping the progress of the disease and, ideally, to reverse it. The amyloid cascade hypothesis based on the fundamental role of amyloid has been the central hypothesis in the last 30 years. However, since amyloid-directed treatments have shown no relevant beneficial results other theories have been postulated to explain the origin of the pathology. The brain is a highly metabolically active energy-consuming tissue in the human body. It has an almost complete dependence on the metabolism of glucose and uses most of its energy for synaptic transmission. Thus, alterations on the utilization or availability of glucose may be cause for the appearance of neurodegenerative pathologies like AD. In this review article, the hypothesis known as Type 3 Diabetes (T3D) will be evaluated by summarizing some of the data that has been reported in recent years. According to published research, the adherence over time to low saturated fatty acids diets in the context of the Mediterranean diet would reduce the inflammatory levels in brain, with a decrease in the pro-inflammatory glial activation and mitochondrial oxidative stress. In this situation, the insulin receptor pathway would be able to fine tune the mitochondrial biogenesis in neuronal cells, regulation the adenosine triphosphate/adenosine diphosphate intracellular balance, and becoming a key factor involved in the preservation of the synaptic connexions and neuronal plasticity. In addition, new targets and strategies for the treatment of AD will be considered in this review for their potential as new pharmacological or non-pharmacological approaches.
Note: Reproducció del document publicat a:
It is part of: Frontiers in Aging Neuroscience, 2019, vol. 6, p. 11-236
Related resource:
ISSN: 1663-4365
Appears in Collections:Articles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia)
Articles publicats en revistes (Institut de Nanociència i Nanotecnologia (IN2UB))
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
693101.pdf1.75 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons